ABSTRACT
INTRODUCTION

Human immunodeficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS)
afflicting millions of people worldwide (11) . Globally, sexual transmission is the major route for HIV infection (1) . Mucosal secretions of the genital tract represent an important vehicle for sexual transmission of HIV (5) . Factors in mucosal secretions may affect HIV expression by infected cells in the genital tract and thus influence sexual transmission of HIV by increasing the amount of virus in the genital tract (7) .
Our laboratory previously reported that 15%-20% of cervicovaginal lavage (CVL) samples, from both HIV seronegative and seropositive women, contained an HIV-inducing factor (HIF) which enhanced HIV replication up to 70-fold (10) . The increased expression of HIV was not due to increased cell proliferation as shown by thymidine uptake studies (10) . HIF induces HIV expression in both monocytoid and T cells through NF κ -B and TRE-mediated activation of the HIV-LTR (2) . Although HIF has been partially characterized (10) , the molecular mass and the structure of HIF is not known. In this report, we describe a novel method that can be used for direct detection of HIF in secretions of the genital tract, as well as determining the molecular mass of HIF. We refer to this method as the "BioBlot" technique for HIV induction, which is a modified version of the "Cell Blot" described by Carnow et al. (3) . It basically involves SDS-PAGE of CVL specimens that contain HIF, followed by electrophoretic transfer of the resolved proteins to nitrocellulose paper. The blot is then sliced and transferred to culture plates and seeded with HIV-infected cells to measure HIV-enhancing activity.
MATERIALS AND METHODS
Cells and Culture Conditions
The U1 cells were obtained from the AIDS Research and Reference ReagentProgram (contributed by Dr. Thomas Folks), Division of AIDS-NI -AID/National Institutes of Health (Rockville, MD, USA). U1 cells are transformed monocytoid cells derived from the U937 cell line and contain a stable copy of the complete HIV-1 IIIB genome (6) . U1 cell cultures were fed twice weekly with a complete medium consisting of RPMI-1640 supplemented with 0.01 M HEPES, 0.002 M glutamine and 10% fetal bovine serum (FBS) (BioWhittakker, Walkerville, MD, USA). Before each experiment, cell viability was checked by trypan blue dye exclusion. The U1 cells were negative for mycoplasma by PCR (9) .
Collection and Preparation of CVL
CVL samples were collected from volunteers in the Women Interagency HIV study (WIHS) at Rush Medical College. For collection of CVL, the cervix and vagina were sequentially irrigated with two 10 mL aliquots of sterile normal saline, which were then pooled. Specimens of CVL were centrifuged (700 ×g ), filtered (0.45 µ m pore size) and stored at -70°C.
Detection of Bioactivity in CVL Samples
HIF activity was measured as previously described (10) . Approximately 2 × 10 4 U1 cells were transferred to microplates in 190 µ L of complete medium. CVL specimens were heated at 100°C for 5 min, and 10 µ L were added to the culture to give a total volume of 200 µ L. After 72 h, levels of p24 in the culture were determined by ELISA (SAIC Frederick, NCI-Frederick Cancer Research and Development Center, Frederick, MD, USA) (10) . Before measuring the p24 concentration, culture supernates were treated with 0.5% Triton ® X-100 (Sigma, St. Louis, MO, USA). Positive controls included TNF-α(50 U/well) and phorbal myristate acetate (PMA) at 25 ng/mL. Negative controls consisted of complete media alone, sterile nitrocellulose paper and nitrocellulose paper from a region outside the protein blot area. The same (+) and (-) CVL samples were used throughout these studies. The protein concentration of (+) and (-) CVL samples were 18 µ g/mL and 92 µ g/mL, respectively, determined by BCA protein assay (Pierce Chemical, Rockford, IL, USA). Testing of 32 CVL samples did not reveal any correlation between total protein in CVL samples and their HIF bioactivity (data not shown). Detection of HIF Activity in CVL Sample Directly Applied to Nitrocellulose Paper
Short Technical Reports
The center of two 5 × 5 cm pieces of nitrocellulose paper were marked by a sterile pipet tip, and each piece received a total 100 µ L of HIF positive or HIF negative CVL samples. First, 50 µ L of CVL were added and allowed to dry under sterile conditions in a laminar flow hood. Then, an additional 50 µ L were added to the center of the paper and allowed to dry. The central region of the papers were then cut to three 1 × 1 cm pieces and were individually placed in the wells of a 48-well culture plate (Corning, New York, NY, USA). The U1 bioassay was carried out as described below.
Electrophoresis
CVL samples were separated in Tris-glycine SDS-PAGE as described by Weber and Osborn (12) . Samples were treated with electrophoresis sample buffer (0.0625 M Tris-HCl, 2.3% SDS, glycerol and 0.05% bromophenol blue (pH 6.8) and heated at 70°C for 10 min in the absence of 5% β -mercaptoethanol. Samples were then loaded on a 12% SDS-polyacrylamide slab gel (gel buffer = 0.375 M Tris-HCl, 0.1% SDS, pH 8.8) with a 3% stacking gel (gel buffer = 0.125 M Tris-HCl, 0.1% SDS, pH 6.8). For each well, 300 µ L of CVL samples corresponded to 5.4 µ g protein of the HIF (+) sample and 27.5 µ g protein of the HIF (-) sample. Electrophoresis was carried out for 4 h at 120 V using a dual vertical slab apparatus (Bio-Rad Laboratories, Hercules, CA, USA) with cooling in an electrophoresis buffer that contained of 0.05 M Tris, 0.192 M glycine and 0.1% SDS, pH 8.3. The apparent molecular masses of the separating proteins were determined using prestained molecular weight markers (Rainbow, Amersham Corporation, UK) that consisted of 200 kDa myosin, 92.5 kDa phosphorylase b, 69 kDa BSA, 46 kDa ovalbumin, 30 kDa carbonic anhydrase, 21.5 kDa trypsin inhibitor and 14.3 kDa lysozyme.
Electroblotting and Silver Staining
After SDS-PAGE, the proteins were electrophoretically transferred onto nitrocellulose paper (Bio-Rad Laboratories) as described previously (8) . The blotting buffer consisted of 0.5 M Tris, 0.38 M glycine, 0.01% SDS and 10% methanol, pH 8.3. The transfer was performed in a blotting apparatus (Hoeffer Scientific Instruments, San Fransisco, CA, USA) at 1 mA for 90 min at 4°C. After the transfer, the blot papers were washed 3 ×with 20 mL of sterile PBS. The blot papers were then sliced into fifteen 7.5 mm sections and transferred to a 48-well culture plate to measure HIV induction activity in U1 cells. Duplicate SDS-PAGE gels that were run simultaneously were stained using a silver staining kit (Bio-Rad Laboratories).
Biological Assays for Electroblotted CVL Sample
To test HIF activity of electroblotted CVLsampleonnitrocellulosepaper, 8×10 4 U1 cells in 0.5 mL complete medium were incubated with slices of nitrocellulose paper in wells of 48-well plates. After 72 h of incubation at 37°C, culture supernatant fluids were collected and, as an indicator of HIV expression, HIV core protein p24 was measured as described above. The HIF positive CVL sample shows threefold higher HIV p24 levels than either the negative CVL or nitrocellulose paper only ( P =0.049, unpaired t-test). Data represent two experiments using triplicate wells. Sample designated as (+) CVL is defined as a sample that induces p24 production by U1 cells ≥fivefold over the basal levels. Samples that do not induce p24 production above fivefold are referred to as (-) CVL.
RESULTS
Detection of HIF after Direct Application of CVL Samples to Nitrocellulose Paper
To determine whether the bioactivity of HIF bound to nitrocellulose can be detected, the CVL samples with or without HIF bioactivity were directly applied onto nitrocellulose paper. The resulting loaded blots were then added to cultures of chronically HIV-infected U1 cells. These cells have been used as a model to test the effects of various substances including cytokines (4) on HIV replication in monocytoid cells. Before the BioBlot assay, the HIF positive (final concentrations of 0.5%) and negative CVL samples were tested for bioactivity. Figure 1 shows that the addition of blot paper with the HIF positive CVL sample increased HIV production by about threefold, while untreated U1 cells produced low levels of HIV. The culture wells that received HIF negative CVL sample or untreated nitrocellulose paper induced levels of p24 protein similar to those of untreated cells. (Figure 1) .
Determination of the Molecular Mass of HIF by BioBlot Assay
To identify the molecular mass of proteins that correspond to HIF activity, HIF positive and negative CVL samples were analyzed by SDS-PAGE, followed by silver staining on a separate gel (sensitivity: 5 ng protein per well). Five distinct visible protein bands were observed in both CVL samples, with apparent molecular masses of approximately 70, 48, 35, 14 and 1 kDa at the migration front (Figure 2) . Unresolved high-molecular-weight aggregates were also present on top of the gel (not shown). None of the visible bands was unique to the HIF(+) CVL sample. This band pattern was similar to patterns previously observed using 30 different (+) CVL samples (not shown).
To determine the bioactive bands, two CVL samples, with and without HIF bioactivity, were run on a nonreducing SDS-PAGE gel and followed by electroblotting of the samples as described above. After incubation of U1 cells with blot paper, slices from two adjacent regions of the HIF positive CVL blot, corresponding to molecular mass of approximately 16 and 14 kDa, showed the highest HIV enhancing activity (Figure 3) . The degree of HIV enhancement was 8-fold and 15-fold higher than that of the untreated U1 cells. Blot slices from other sections of the HIF positive CVL sample showed near basal levels of HIF bioactivity. Moreover, blot slices from all regions of the HIF negative CVL sample, as well as regions of the blot that were not treated with CVL sample, showed no induction of HIV in U1 cells. The results in Figure 3 show that the BioBlot technique was able to detect HIF bioactivity after the SDS-PAGE/electroblotting procedures and that HIF has a molecular mass of 14 kDa.
DISCUSSION
We have developed a novel method for two potentially important applications: first, the detection of an HIF found in the female genital tract secretions and second, the molecular mass determination of HIF. This is the first report to show the usefulness of the BioBlot assay technique for measuring bioactivity of HIV activating factors and molecular weight determinations of proteins from genital tract secretions.
The BioBlot assay is similar to the Cell Blot technique developed by Carnow et al. (7) and makes use of the electrophoretic mobility of ciliary neurotrophic factors by staining live neurons growing in a region on nitrocellulose paper. The Cell Blot technique has also been used to study molecules such as nerve growth factors (8) . The ability to detect HIF bioactivity after binding to nitrocellulose paper suggests that functional sites of HIF are available and that protein refolding during denaturation and SDS treatment does not abolish the HIF bioactivity. Because protein binding to nitrocellulose paper is stable and difficult to reverse without harsh enzymatic treatment, the detection of HIF bioactivity anchored to nitrocellulose paper also suggests that HIF can exert its HIV-inducing effects The BioBlot technique offers many advantages over methods that test a sample's bioactivity directly in solution. For example, in addition to enabling investigators to determine the molecular mass of the compound of interest, it allows for removing possible cytotoxic substances such as inorganic molecules, toxins, proteases and salts or other interfering substances from specimens. This can be simply achieved by binding the protein of interest to nitrocellulose paper with subsequent washing of the blot before bioassays.
INTRODUCTION
Labeling of oligonucleotides is important for screening gene libraries using hybridization methods (10) . A variety of nonisotopic labeling reactions are used for introducing a labeling molecule to a 3 ′ -or 5 ′ -end (3,4,7), some internal nucleotides (12) or the 3 ′ -tail (5) . Specificity to the oligonucleotide sequence is high when using end labeling; however, the sensitivity is low with nonisotopic labeling. The highest sensitivity is obtained by tailing, using DIG-labeled nucleotide in combination with deoxyadenosine-5 ′ -triphosphate (dATP) as substrates of terminal deoxynucleotidyl transferase (TdT); however, the specificity is often reduced due to the added tail. This is especially true in screening cDNA clones: the homopolymeric dA tail hybridizes to dA/dT regions in the cDNA clones derived from poly(A) sequences of eukaryotic mRNA (2) even if the regions in the cDNA are masked by the addition of unlabeled poly(dA) oligonucleotides. Thus, there has been no nonisotopic method of labeling an oligonucleotide probe for sensitive and specific cDNA screening using hybridization. In this study, we used deoxyinosine-5 ′ -triphosphate (dITP) in combination with DIG-deoxyuridine-5 ′ -triphosphate (DIG-dUTP) as the substrate for TdT tailing. The efficiency of labeling and the specificity of hybridization of the probe were evaluated in comparison with probes tailed with dATP in combination with DIG-dUT
MATERIALS AND METHODS
Materials
dITP was purchased from Sigma (St. Louis, MO, USA). Positively charged nylon membranes were purchased from Roche Molecular Biochemicals (Mannheim, Germany). A synthetic oligonucleotide (5 ′ -CCCTA-CAAAGAAAATGGAGAGCCT-3 ′ ) to detect the testis-enhanced gene transcript ( TEGT ) gene was designed using an HYBsimulator ™ (Advanced Gene Computing Technologies, Irvine, CA, USA). For the colony hybridization experiment, 275 types of synthetic oligonucleotides were designed. Synthetic oligonucleotides were purchased from Life Technologies (Gaithersburg, MD, USA). Plasmid DNA containing cDNA clones was obtained from a cDNA library (11) .
Tailing of Oligonucleotide Using TdT
Oligonucleotide probes were tailed with DIG-labeled nucleotide using TdT
